| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |